Oscar Health (NYSE:OSCR) Reaches New 12-Month Low - Time to Sell?

Oscar Health, Inc. (NYSE:OSCR - Get Free Report) reached a new 52-week low on Monday . The company traded as low as $11.28 and last traded at $11.33, with a volume of 922921 shares trading hands. The stock had previously closed at $12.03.

Analyst Upgrades and Downgrades

Separately, Wells Fargo & Company lowered shares of Oscar Health from an "overweight" rating to an "equal weight" rating and dropped their price target for the stock from $20.00 to $16.00 in a research report on Thursday, March 13th. Two investment analysts have rated the stock with a sell rating, three have given a hold rating, two have issued a buy rating and one has assigned a strong buy rating to the stock. Based on data from MarketBeat.com, the company presently has an average rating of "Hold" and a consensus target price of $20.21.

Oscar Health Stock Performance

The stock's 50-day simple moving average is $13.63 and its 200 day simple moving average is $14.88. The company has a quick ratio of 0.73, a current ratio of 0.73 and a debt-to-equity ratio of 0.26. The stock has a market capitalization of $3.03 billion, a price-to-earnings ratio of -604.45 and a beta of 1.75.

Oscar Health (NYSE:OSCR - Get Free Report) last announced its earnings results on Tuesday, February 4th. The company reported ($0.62) EPS for the quarter, missing the consensus estimate of ($0.55) by ($0.07). Oscar Health had a return on equity of 2.28% and a net margin of 0.28%. Analysts expect that Oscar Health, Inc. will post 0.69 earnings per share for the current fiscal year.

Hedge Funds Weigh In On Oscar Health

Institutional investors have recently modified their holdings of the stock. Vanguard Group Inc. raised its position in Oscar Health by 3.2% in the 4th quarter. Vanguard Group Inc. now owns 18,997,973 shares of the company's stock worth $255,333,000 after purchasing an additional 586,626 shares during the last quarter. Deerfield Management Company L.P. Series C increased its stake in shares of Oscar Health by 50.7% in the 4th quarter. Deerfield Management Company L.P. Series C now owns 11,835,000 shares of the company's stock valued at $159,062,000 after buying an additional 3,983,325 shares during the period. JPMorgan Chase & Co. raised its position in shares of Oscar Health by 348.7% during the fourth quarter. JPMorgan Chase & Co. now owns 10,360,529 shares of the company's stock worth $139,246,000 after acquiring an additional 8,051,379 shares during the last quarter. Thrive Capital Management LLC raised its position in shares of Oscar Health by 33.4% during the fourth quarter. Thrive Capital Management LLC now owns 6,343,617 shares of the company's stock worth $85,258,000 after acquiring an additional 1,588,395 shares during the last quarter. Finally, Gilder Gagnon Howe & Co. LLC lifted its stake in shares of Oscar Health by 51.4% during the fourth quarter. Gilder Gagnon Howe & Co. LLC now owns 6,335,862 shares of the company's stock valued at $85,154,000 after acquiring an additional 2,151,256 shares during the period. 75.70% of the stock is owned by institutional investors.

About Oscar Health

Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.